# Wintrust Financial Corp: financial statements, quarterly

WTFC · Nasdaq · CIK 1015328 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/wtfc.md) · [Financials](/companies/wtfc/financials.md) · [Filings](/companies/wtfc/filings.md) · [Insiders](/companies/wtfc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wtfc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [575](/filings/0001015328-24-000253.md) | [(1,481) d](/filings/0001015328-26-000007.md) | [605](/filings/0001015328-24-000143.md) | [592](/filings/0001015328-24-000187.md) | [616](/filings/0001015328-24-000253.md) | [(1,562) d](/filings/0001015328-26-000007.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [300](/filings/0001015328-24-000253.md) | [324 d](/filings/0001015328-26-000007.md) | [341](/filings/0001015328-25-000130.md) | [379](/filings/0001015328-25-000188.md) | [406](/filings/0001015328-25-000207.md) | [388 d](/filings/0001015328-26-000007.md) | [360](/filings/0001015328-26-000014.md) | [374](/filings/0001015328-26-000022.md) | [397](/filings/0001015328-25-000207.md) | [372 d](/filings/0001015328-26-000007.md) | [349](/filings/0001015328-26-000014.md) | [364](/filings/0001015328-26-000022.md) |
| Income tax | $m | [60.7](/filings/0001015328-24-000253.md) | [41.8 d](/filings/0001015328-26-000007.md) | [62.7](/filings/0001015328-25-000130.md) | [59.0](/filings/0001015328-25-000188.md) | [62.7](/filings/0001015328-25-000207.md) | [67.7 d](/filings/0001015328-26-000007.md) | [64.0](/filings/0001015328-26-000014.md) | [71.6](/filings/0001015328-26-000022.md) | [79.8](/filings/0001015328-25-000207.md) | [79.2 d](/filings/0001015328-26-000007.md) | [73.6](/filings/0001015328-26-000014.md) | [84.3](/filings/0001015328-26-000022.md) |
| Net income | $m | [164](/filings/0001015328-24-000253.md) | [123 d](/filings/0001015328-26-000007.md) | [187](/filings/0001015328-25-000130.md) | [152](/filings/0001015328-25-000188.md) | [170](/filings/0001015328-25-000207.md) | [185 d](/filings/0001015328-26-000007.md) | [189](/filings/0001015328-26-000014.md) | [196](/filings/0001015328-26-000022.md) | [216](/filings/0001015328-25-000207.md) | [223 d](/filings/0001015328-26-000007.md) | [227](/filings/0001015328-26-000014.md) | [234](/filings/0001015328-26-000022.md) |
| Diluted EPS | $ per share | [2.53](/filings/0001015328-24-000253.md) | not reported | [2.89](/filings/0001015328-25-000130.md) | [2.32](/filings/0001015328-25-000188.md) | [2.47](/filings/0001015328-25-000207.md) | not reported | [2.69](/filings/0001015328-26-000014.md) | [2.78](/filings/0001015328-26-000022.md) | [2.78](/filings/0001015328-25-000207.md) | not reported | [3.22](/filings/0001015328-26-000014.md) | [3.30](/filings/0001015328-26-000022.md) |
| Basic EPS | $ per share | [2.57](/filings/0001015328-24-000253.md) | not reported | [2.93](/filings/0001015328-25-000130.md) | [2.35](/filings/0001015328-25-000188.md) | [2.51](/filings/0001015328-25-000207.md) | not reported | [2.73](/filings/0001015328-26-000014.md) | [2.82](/filings/0001015328-26-000022.md) | [2.82](/filings/0001015328-25-000207.md) | not reported | [3.26](/filings/0001015328-26-000014.md) | [3.34](/filings/0001015328-26-000022.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [55.6](/filings/0001015328-24-000253.md) | [56.3](/filings/0001015328-26-000007.md) | [57.6](/filings/0001015328-25-000130.md) | [59.8](/filings/0001015328-25-000188.md) | [63.8](/filings/0001015328-25-000207.md) | [64.9](/filings/0001015328-26-000007.md) | [65.9](/filings/0001015328-26-000014.md) | [69.0](/filings/0001015328-26-000022.md) | [69.6](/filings/0001015328-25-000207.md) | [71.1](/filings/0001015328-26-000022.md) | [72.2](/filings/0001015328-26-000014.md) | [74.7](/filings/0001015328-26-000022.md) |
| Total liabilities | $bn | [50.5](/filings/0001015328-24-000253.md) | [50.9](/filings/0001015328-25-000093.md) | [52.1](/filings/0001015328-25-000130.md) | [54.2](/filings/0001015328-25-000188.md) | [57.4](/filings/0001015328-25-000207.md) | [58.5](/filings/0001015328-26-000007.md) | [59.3](/filings/0001015328-26-000014.md) | [61.8](/filings/0001015328-26-000022.md) | [62.6](/filings/0001015328-25-000207.md) | [63.9](/filings/0001015328-26-000022.md) | [64.8](/filings/0001015328-26-000014.md) | [67.1](/filings/0001015328-26-000022.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | [0.0](/filings/0001015328-24-000253.md) | [0.0](/filings/0001015328-25-000093.md) | [0.0](/filings/0001015328-25-000130.md) | [0.0](/filings/0001015328-24-000187.md) | [0.0](/filings/0001015328-24-000253.md) | [0.0](/filings/0001015328-25-000130.md) | [0.0](/filings/0001015328-25-000130.md) | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [5.0](/filings/0001015328-24-000253.md) | [5.4](/filings/0001015328-26-000007.md) | [5.4](/filings/0001015328-25-000188.md) | [5.5](/filings/0001015328-25-000207.md) | [6.4](/filings/0001015328-25-000207.md) | [6.3](/filings/0001015328-26-000022.md) | [6.6](/filings/0001015328-26-000022.md) | [7.2](/filings/0001015328-26-000022.md) | [7.0](/filings/0001015328-25-000207.md) | [7.3](/filings/0001015328-26-000022.md) | [7.4](/filings/0001015328-26-000022.md) | [7.5](/filings/0001015328-26-000022.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [88.3 d](/filings/0001015328-24-000253.md) | [248 d](/filings/0001015328-26-000007.md) | [71.1](/filings/0001015328-25-000130.md) | [221 d](/filings/0001015328-25-000188.md) | [(61.6) d](/filings/0001015328-25-000207.md) | [491 d](/filings/0001015328-26-000007.md) | [120](/filings/0001015328-26-000014.md) | [329 d](/filings/0001015328-26-000022.md) | [210 d](/filings/0001015328-25-000207.md) | [252 d](/filings/0001015328-26-000007.md) | [927](/filings/0001015328-26-000014.md) | [255 d](/filings/0001015328-26-000022.md) |
| Capital expenditure | $m | [19.9 d](/filings/0001015328-24-000253.md) | [17.2 d](/filings/0001015328-26-000007.md) | [10.6](/filings/0001015328-24-000143.md) | [39.2 d](/filings/0001015328-24-000187.md) | [16.7 d](/filings/0001015328-24-000253.md) | [19.6 d](/filings/0001015328-26-000007.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [31.5 d](/filings/0001015328-24-000253.md) | [31.4 d](/filings/0001015328-26-000007.md) | [34.2](/filings/0001015328-25-000130.md) | [35.2 d](/filings/0001015328-25-000188.md) | [36.9 d](/filings/0001015328-25-000207.md) | [36.9 d](/filings/0001015328-26-000007.md) | [40.3](/filings/0001015328-26-000014.md) | [40.5 d](/filings/0001015328-26-000022.md) | [46.8 d](/filings/0001015328-25-000207.md) | [41.9 d](/filings/0001015328-26-000007.md) | [45.4](/filings/0001015328-26-000014.md) | [45.5 d](/filings/0001015328-26-000022.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [61.6](/filings/0001015328-23-000204.md) | [61.8](/filings/0001015328-24-000143.md) | [62.1](/filings/0001015328-24-000187.md) | [62.2](/filings/0001015328-24-000253.md) | [62.4](/filings/0001015328-25-000130.md) | [62.8](/filings/0001015328-25-000188.md) | [65.9](/filings/0001015328-25-000207.md) | [67.6](/filings/0001015328-26-000014.md) | [67.8](/filings/0001015328-26-000022.md) | [68.0](/filings/0001015328-25-000207.md) | [68.1](/filings/0001015328-26-000014.md) | [68.3](/filings/0001015328-26-000022.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 67,465,967 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0001015328-26-000022.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.